HealthLynked Corp. (HLYK)
OTCMKTS
· Delayed Price · Currency is USD
0.0250
+0.0004 (1.63%)
Apr 24, 2025, 4:00 PM EDT
HealthLynked Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 2.98 | 5.66 | 5.84 | 6.48 | 5.37 | Upgrade
|
| Other Revenue | 0.03 | 0.06 | 0.02 | 0.01 | - | Upgrade
|
| Revenue | 3.01 | 5.72 | 5.86 | 6.5 | 5.37 | Upgrade
|
| Revenue Growth (YoY) | -47.43% | -2.32% | -9.83% | 21.09% | 33.51% | Upgrade
|
| Cost of Revenue | 2.09 | 3.37 | 3.8 | 3.72 | 2.73 | Upgrade
|
| Gross Profit | 0.92 | 2.35 | 2.06 | 2.78 | 2.64 | Upgrade
|
| Selling, General & Admin | 3.04 | 3.62 | 4.58 | 4.93 | 3.06 | Upgrade
|
| Other Operating Expenses | 1.56 | 2.21 | 2.57 | 2.35 | 2.4 | Upgrade
|
| Operating Expenses | 4.88 | 6.18 | 7.97 | 8.11 | 5.71 | Upgrade
|
| Operating Income | -3.96 | -3.83 | -5.91 | -5.33 | -3.07 | Upgrade
|
| Interest Expense | -1.48 | -0.5 | -0.08 | -0.02 | -0.78 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | -0.11 | - | 0.74 | Upgrade
|
| EBT Excluding Unusual Items | -5.45 | -4.33 | -6.1 | -5.35 | -3.11 | Upgrade
|
| Impairment of Goodwill | - | -0.32 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.28 | Upgrade
|
| Asset Writedown | -0.72 | - | -2.75 | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | -0.71 | Upgrade
|
| Other Unusual Items | 0.03 | 1.04 | 0.78 | -5.35 | -1.65 | Upgrade
|
| Pretax Income | -6.13 | -3.61 | -8.07 | -10.7 | -5.76 | Upgrade
|
| Earnings From Continuing Operations | -6.13 | -3.61 | -8.07 | -10.7 | -5.76 | Upgrade
|
| Earnings From Discontinued Operations | - | 2.6 | -0.75 | 0.29 | - | Upgrade
|
| Net Income | -6.13 | -1.01 | -8.82 | -10.41 | -5.76 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | 0.35 | 0.35 | 0.45 | Upgrade
|
| Net Income to Common | -6.13 | -1.01 | -9.17 | -10.77 | -6.2 | Upgrade
|
| Shares Outstanding (Basic) | 282 | 263 | 243 | 225 | 143 | Upgrade
|
| Shares Outstanding (Diluted) | 282 | 263 | 243 | 225 | 143 | Upgrade
|
| Shares Change (YoY) | 7.09% | 8.00% | 8.35% | 57.30% | 44.18% | Upgrade
|
| EPS (Basic) | -0.02 | -0.00 | -0.04 | -0.05 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.00 | -0.04 | -0.05 | -0.04 | Upgrade
|
| Free Cash Flow | -3.5 | -4.15 | -4.39 | -3.79 | -2.14 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.02 | -0.02 | -0.02 | -0.01 | Upgrade
|
| Gross Margin | 30.48% | 41.05% | 35.15% | 42.72% | 49.16% | Upgrade
|
| Operating Margin | -131.69% | -66.96% | -100.95% | -82.05% | -57.25% | Upgrade
|
| Profit Margin | -203.81% | -17.69% | -156.52% | -165.71% | -115.58% | Upgrade
|
| Free Cash Flow Margin | -116.23% | -72.46% | -74.88% | -58.32% | -39.93% | Upgrade
|
| EBITDA | -3.85 | -3.71 | -5.08 | -4.5 | -2.82 | Upgrade
|
| EBITDA Margin | -127.86% | -64.80% | -86.79% | -69.31% | -52.64% | Upgrade
|
| D&A For EBITDA | 0.12 | 0.12 | 0.83 | 0.83 | 0.25 | Upgrade
|
| EBIT | -3.96 | -3.83 | -5.91 | -5.33 | -3.07 | Upgrade
|
| EBIT Margin | -131.69% | -66.96% | -100.95% | -82.05% | -57.25% | Upgrade
|
| Revenue as Reported | 3.01 | 5.72 | 5.86 | 6.5 | 6.13 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.